Abstract

Abstract Aim To determine whether trans oral laser microsurgery or radiotherapy is the more cost-effective modality in treating patients with T1b-T2 glottic tumours Method Ten-year data was retrospectively collected from all patients who presented with T1-T2 glottic cancer. The individual components of the cost associated with trans oral laser microsurgery and radiotherapy were ascertained. The total cost was calculated and the average cost of each modality per patient was compared. Results Theatre operating fees were the most significant cost associated with trans oral laser microsurgery, whereas delivery of radiotherapy per fraction was the most significant cost in radiation treatment. The cost for trans oral laser microsurgery was estimated to be £1120.34 whereas the cost of radiotherapy was £3754.6. Conclusions Trans oral laser microsurgery appears to be more cost effective compared to radiotherapy in early glottic cancer management.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call